At a glance
ClinicalIndex Comparison RecordN/ACompleted· 600 enrolled
Drug / intervention
case series review of clinical dataother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Prognostic Value of Serum Biomarkers in Osteosarcoma
In Brief
An observational study evaluating case series review of clinical data for Osteosarcoma. Completed, enrolled 600 participants across 1 site.
Detailed Summary
Observational retrospective cohort study using laboratory data of blood tests prior to surgical and chemotherapy treatment and other histologic, clinical, and instrumental data related to patient history from digitized medical records and analysis of the same as predictors of outcomes.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsOsteosarcoma
CountriesItaly
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
Enrollment StartJul 2021
First PostedOct 2021
Primary CompletionDec 2021
TodayJul 2026
First PostedOct 26, 2021
Enrollment StartJul 12, 2021
Primary CompletionDec 22, 2021
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 4.7 years ago
Interventions
case series review of clinical dataother
Extraction of pre-surgical and chemotherapy blood test laboratory data and clinical and instrumental data related to patient history from digitized medical records and analysis